首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Aberrant expression and mechanism of miR-130b-3p/phosphatase and tensin homolog in nephroblastoma in children
【2h】

Aberrant expression and mechanism of miR-130b-3p/phosphatase and tensin homolog in nephroblastoma in children

机译:儿童肾母细胞瘤中miR-130b-3p /磷酸酶和张力蛋白同源基因的异常表达及其机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nephroblastoma is the most common renal tumor in children. Abnormal expression of microRNAs (miRs) has been reported to be involved in the progression of various types of cancers. However, the role and underlying mechanism of miR-130b-3p in nephroblastoma remains unknown. Therefore, the present study aimed to explore the role and possible mechanism of miR-130b-3p in nephroblastoma in children. The present study identified that miR-130b-3p was highly expressed in nephroblastoma tissues obtained from children with nephroblastoma. To better understand the functions and the molecular mechanisms of miR-130b-3p in nephroblastoma, TargetScan was used to identify the potential targets of miR-130b-3p. Phosphatase and tensin homolog (PTEN), was identified as a target gene of miR-130b-3p, and it was observed to be downregulated in nephroblastoma. Further analysis indicated that miR-130b-3p inhibitor could significantly reduce cell proliferation, induce apoptosis and suppress the Aktuclear factor-κB/survivin signaling pathway in nephroblastoma cells. Notably, all these effects of miR-130b-3p on nephroblastoma cells were reversed by PTEN-small interfering RNA. In summary, the present study suggested that the miR-130b-3p/PTEN axis could serve a critical role in the progression and development of nephroblastoma. It also suggests that miR-130b-3p might be a valuable clinical biomarker and therapeutic target for nephroblastoma in children.
机译:肾母细胞瘤是儿童中最常见的肾肿瘤。据报道,microRNA(miRs)的异常表达与各种类型的癌症的发展有关。但是,miR-130b-3p在肾母细胞瘤中的作用和潜在机制尚不清楚。因此,本研究旨在探讨miR-130b-3p在儿童肾母细胞瘤中的作用和可能的机制。本研究确定了miR-130b-3p在从肾母细胞瘤儿童获得的肾母细胞瘤组织中高表达。为了更好地了解miR-130b-3p在肾母细胞瘤中的功能和分子机制,使用TargetScan鉴定了miR-130b-3p的潜在靶标。磷酸酶和张力蛋白同源物(PTEN)被鉴定为miR-130b-3p的靶基因,并且在肾母细胞瘤中被观察到下调。进一步的分析表明,miR-130b-3p抑制剂可显着降低肾母细胞瘤细胞的细胞增殖,诱导细胞凋亡并抑制Akt /核因子-κB/ survivin信号通路。值得注意的是,miR-130b-3p对肾母细胞瘤细胞的所有这些作用都被PTEN-小干扰RNA逆转了。总之,本研究表明,miR-130b-3p / PTEN轴可能在肾母细胞瘤的进展和发展中起关键作用。这也表明miR-130b-3p可能是儿童肾母细胞瘤的有价值的临床生物标志物和治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号